Asthma, influenza, and vaccination

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 6, 2006, Pages 1199-1206

  Glezen, W Paul ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Asthma in children; inactivated and live attenuated; influenza vaccines; influenza triggered asthma exacerbations; safety and efficacy of influenza vaccines in children with asthma

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; HEMAGGLUTININ; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEMBRANE ANTIGEN; MUSCARINIC M2 RECEPTOR ANTAGONIST; OSELTAMIVIR; RIMANTADINE; SIALIDASE; STEROID; TRIPLE VACCINE; TRIVALENT COLD ADAPTED INFLUENZA VACCINE; VIRUS RNA; ZANAMIVIR;

ASTHMA; CHILDHOOD DISEASE; DISEASE EXACERBATION; DRUG DOSE COMPARISON; DRUG SAFETY; EPIDEMIC; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFLUENZA VIRUS C; NONHUMAN; ORTHOMYXOVIRUS; PRIORITY JOURNAL; REVIEW; UNITED STATES; VACCINATION; VIRUS INFECTION; WHEEZING;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; UNITED STATES; VACCINATION;

EID: 33845225731     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.08.032     Document Type: Review

References (43)

1. Eggleston P.A. Asthma. In: McMillan J.A., Feigin R.D., DeAngelis C., and Jones M.D. (Eds). Oski's pediatrics (2006), Lippincott Williams & Wilkins, Philadelphia 2404-2410
2. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., and Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283 (2000) 499-505
3. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., and Halonen M. Asthma and wheezing in the first six years of life. N Engl J Med 332 (1995) 133-138
4. Glezen W.P. Reactive airway disorders in children: role of respiratory viruses. Clin Chest Med 5 (1984) 635-643
5. Atmar R.L., Guy E., Guntupalli K.K., Simmerman J.L., Bandi V.D., Baxter B.D., et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 158 (1998) 2453-2459
6. Heymann P.W., Platts-Mills T.A.E., and Johnston S.L. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J 24 (2005) S217-S222
7. Tan W.C. Viruses in asthma exacerbations. Curr Opin Pulm Med 11 (2004) 21-26
8. Van den Hoogen B.G., De Jong J.C., Groen J., Kuiken T., De Groot R., Fouchier R.A.M., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 (2001) 719-724
9. Laham F.R., Israele V., Casellas J.M., Garcia A.M., Lac Prugent C.M., Hoffman S.J., et al. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis 189 (2004) 2047-2056
10. Sumino K.C., Agapov E., Pierce R.A., Trulock E.P., Pfeiffer J.D., Ritter J.H., et al. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathologic assessment. J Infect Dis 192 (2005) 1052-1060
11. Esper F., Martinello R.A., Boucher D., Weibel C., Ferguson D., Landry M.L., et al. A 1-year experience with human metapneumovirus in children aged <5 years. J Infect Dis 189 (2004) 1388-1396
12. Glezen W.P. Influenza viruses. In: Feigin R.D., Cherry J.D., Demmler G.J., and Kaplan S.L. (Eds). Textbook of pediatric infectious diseases (2004), Saunders, Philadelphia 2252-2269
13. Webby R.J., and Webster R.G. Are we ready for pandemic influenza?. Science 302 (2003) 1519-1522
14. Govorkova E.A., Webby R.J., Humberd J., Seiler J.P., and Webster R.G. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 194 (2006) 159-167
15. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 (2005) 77-79
16. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
17. Smith C.B., Cox N.J., Subbarao K., Taber L.H., and Glezen W.P. Molecular epidemiology of influenza A(H3N2) virus reinfections. J Infect Dis 185 (2002) 980-985
18. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004) 1333-1340
19. Glezen W.P. The changing epidemiology of respiratory syncytial virus and influenza. Pediatr Infect Dis J 23 (2004) S202-S206
20. Neuzil K.M., Wright P.F., Mitchel Jr. E.F., and Griffin M.R. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 137 (2000) 856-864
21. Kramarz P., DeStefano F., Gargiullo P.M., Davis R.L., Chen R.T., Mullooly J.P., et al. Does influenza vaccination exacerbate asthma?. Arch Fam Med 9 (2000) 617-623
22. Park C.L., Frank A.L., Sullivan M., Jindal P., and Baxter B.D. Influenza vaccination of children during acute asthma exacerbations and concurrent prednisone therapy. Pediatrics 98 (1996) 196-200
23. Hanania N.A., Sockrider M., Castro M., Holbrook J.T., Tonascia J., Wise R., et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 113 (2004) 717-724
24. Kramarz P., DeStefano F., Gargiullo P.M., Chen R.T., Lieu T.A., Davis D.L., et al. Does influenza vaccination prevent asthma exacerbations in children?. J Pediatr 138 (2001) 306-310
25. Sugaya N., Nerome K., Ishida M., Matsumoto M., Mitamura K., Nirasawa M., et al. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 272 (1994) 153-159
26. Christy C., Aligne C.A., Auinger P., Pukino T., and Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 89 (2004) 734-735
27. Hak E., Hoes A.W., Grobbee D.E., Lammers J.W.J., van Essen G.A., van Loon A.M., et al. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. Am J Epidemiol 157 (2003) 692-700
28. Bueving H.J., Bernsen R.M.D., de Jongste J.C., van Suijlekom-Smit L.W.A., Rimmelzwaan G.F., Osterhaus A.D.M.E., et al. Influenza vaccination in children with asthma. Am J Respir Crit Care Med 169 (2004) 488-493
29. Glezen W.P. New vaccines for old diseases: trivalent cold-adapted influenza vaccine. Pediatr Ann 33 (2004) 545-550
30. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent with trivalent inactivated influenza vaccine in children and adolescents with asthma. Pediatr Infect Dis J (2006) In press
31. Bergen R., Black S., Shinefield H., Lewis E., Ray P., Hansen J., et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 23 (2004) 138-144
32. Piedra P.A., Gaglani M.J., Riggs M., Herschler G., Fewlass C., Watts M., et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, non-randomized, open-label trial. Pediatrics 116 (2005) e397-e407
33. Piedra P.A., Yan L., Kotloff K., Zangwill K., Bernstein D.I., King J., et al. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children. Pediatrics 110 (2002) 662-672
34. Redding G., Walker R.E., Hessel C., Virant F.S., Ayars G.H., Bensch G., et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 21 (2002) 44-48
35. Clover R.D., Crawford S., Glezen W.P., Taber L.H., Matson C.C., and Couch R.B. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 163 (1991) 300-304
36. Piedra P.A., and Glezen W.P. Influenza in children: epidemiology, immunity and vaccines. Semin Pediatr Infect Dis 2 (1991) 140-146
37. Gaglani M.J., Piedra P.A., Herschler G.B., Griffith M.E., Kozinetz C.A., Riggs M.W., et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 158 (2004) 65-73
38. Halloran M.E., Longini Jr. I.M., Gaglani M.J., Piedra P.A., Chu H., Herschler G.B., et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A(H1N1) and B using surveillance cultures. Am J Epidemiol 158 (2003) 305-311
39. Ashkenazi S., Vertruyen A., Aristegui J., Principi N., McKeith D., Kremola T., et al. Comparison of efficacy and safety of a trivalent live, attenuated, intranasal influenza vaccine (CAIV-T) with trivalent inactivated, intramuscular influenza vaccine (TIV) in children aged 6 to <72 months with a history of respiratory tract infections. Pediatr Infect Dis J (2006) In press
40. Belshe R. Comparison of the efficacy and safety of cold-adapted influenza vaccine, trivalent (CAIV-T) with trivalent inactivated influenza vaccine (TIV) in children 6-59 months of age. Presented at the Pediatric Academic Societies Meeting, April 29-May 2, 2006.
41. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., and Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344 (2001) 889-896
42. Harper S.A., Fukuda K., Uyeki T.M., Cox N.J., and Bridges C.B. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 (2005) 1-40
43. Johnston S.L., Ferrero F., Garcia M.L., and Dutkowski R. Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma. Pediatr Infect Dis J 24 (2005) 225-232